SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001262463-14-000150
Filing Date
2014-02-19
Accepted
2014-02-19 14:46:46
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plpl123113q.htm 10-Q 195526
2 EXHIBIT 4.2 ex42.htm EX-4 10980
3 EXHIBIT 31.1 ex311.htm EX-31 7835
4 EXHIBIT 31.2 ex312.htm EX-31 7831
5 EXHIBIT 32.1 ex321.htm EX-32 4066
  Complete submission text file 0001262463-14-000150.txt   2222096

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE plpl-20131231.xml EX-101.INS 178422
7 XBRL SCHEMA FILE plpl-20131231.xsd EX-101.SCH 28966
8 XBRL CALCULATION FILE plpl-20131231_cal.xml EX-101.CAL 48933
9 XBRL DEFINITION FILE plpl-20131231_def.xml EX-101.DEF 98869
10 XBRL LABEL FILE plpl-20131231_lab.xml EX-101.LAB 204235
11 XBRL PRESENTATION FILE plpl-20131231_pre.xml EX-101.PRE 164083
Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102
Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 (435) 881-8734
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

IRS No.: 453642179 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-51206 | Film No.: 14625251
SIC: 2834 Pharmaceutical Preparations